New tool aims to help breast cancer patients decide on preventive surgery
NCT ID NCT02918474
First seen Nov 03, 2025 · Last updated Jun 23, 2026 · Updated 35 times
Summary
This study tests a decision-making tool for women newly diagnosed with breast cancer who are considering whether to have the healthy breast removed preventively (contralateral prophylactic mastectomy). The tool is designed to provide clear, balanced information. Researchers will measure how acceptable the tool is, whether it improves patients' knowledge, and whether it reduces uncertainty about the decision. The study enrolls 15 participants with early-stage breast cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE III BREAST CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this tool could help patients make more informed, confident decisions about their surgical options.
What could go wrong
This is a very small early study (15 participants) testing a tool, not a treatment. It may not show clear benefits or apply to all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.